Tyche Wealth Partners LLC Novartis Ag Transaction History
Tyche Wealth Partners LLC
- $462 Billion
- Q1 2025
A detailed history of Tyche Wealth Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 2,244 shares of NVS stock, worth $259,765. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,244
Previous 2,247
0.13%
Holding current value
$259,765
Previous $219 Million
14.41%
% of portfolio
0.05%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...